Showing results (131-140 of 220) with videos related to

Sort By:
Pageof 22
The American Journal of Gastroenterology|September 13, 2008
Defining the optimal response criteria for the Crohn's disease activity index for induction studies in patients with mildly to moderately active Crohn's diseaseKelvin T Thia, William J Sandborn, James D Lewis, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 12, 2018
Efficacy and Follow-up of Segmental or Subtotal Colectomy in Patients With Colitis-Associated NeoplasiaNoa Krugliak Cleveland, Jacob E Ollech, Ruben J Colman, et al.
Inflammatory Bowel Diseases|October 29, 2005
Design issues and outcomes in IBD clinical trialsBruce E Sands, Maria T Abreu, George D Ferry, et al.
Gastroenterology|January 24, 2007
Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trialJean-Frédéric Colombel, William J Sandborn, Paul Rutgeerts, et al.
Inflammatory Bowel Diseases|March 18, 2026
Recovery of response and long-term outcomes following loss of response and dose escalation of subcutaneous infliximab: a post hoc analysis of the LIBERTY-CD & LIBERTY-UC trialsMarla C Dubinsky, Stefan Schreiber, Andres J Yarur, et al.
Inflammatory Bowel Diseases|June 15, 2007
Rifaximin for the treatment of active pouchitis: a randomized, double-blind, placebo-controlled pilot studyKim L Isaacs, Robert S Sandler, Maria Abreu, et al.
Gastroenterology|September 22, 2009
Delayed-release oral mesalamine 4.8 g/day (800-mg tablet) is effective for patients with moderately active ulcerative colitisWilliam J Sandborn, Jaroslaw Regula, Brian G Feagan, et al.
Lancet (London, England)|June 6, 2002
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trialStephen B Hanauer, Brian G Feagan, Gary R Lichtenstein, et al.
Gastroenterology|February 6, 2004
Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's diseasePaul Rutgeerts, Brian G Feagan, Gary R Lichtenstein, et al.
Digestive Diseases and Sciences|February 8, 2012
Assessment of variables associated with smoking cessation in Crohn's diseaseYvette Leung, Gil G Kaplan, Kevin P Rioux, et al.
Pageof 22